MedTrace Logo

Biomarkers and Volumetric Capnography in BPD

NCT02083562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2018-09-11

No results posted yet for this study

Summary

The purpose of this study is to assess the association of biomarkers on day 7 of life with the development of bronchopulmonary dysplasia in very preterm infants. Additionally a short lung function test at 36 weeks postmenstrual age (PMA) will be performed to investigate whether certain capnographic indices are able to reflect the degree of lung disease.

Protocol was amended (under others: additional enrollment of 70 subjects).

Conditions

  • Bronchopulmonary Dysplasia

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Roland P Neumann, MD · Department of Neonatology, University Children's Hospital Basel, Basel, Switzerland

Eligibility

Min Age
5 Days
Max Age
9 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02083562 on ClinicalTrials.gov